News

For over 15 years, Cheryl Kennedy has been a driving force behind BNAC’s clinical excellence. From navigating international trials to ensuring ethical integrity, she has shaped our research culture through a rare blend of precision, integrity, and leadership.

BNAC demonstrated a strong presence at the 2025 ACTRIMS Forum. The team shared innovative work spanning a wide range of MS research including neuroimaging phenotyping, lymphatic system dysfunction, proteomics, and connectome vulnerability. A platform presentation about the team's landmark secondary analysis of ORATORIO trial showed how artificial intelligence and advanced post-processing techniques were used to detect cortical lesions.

A recent study conducted by a BNAC research team led by Jack Reeves, a Ph.D. candidate, showed that an imaging marker called “paramagnetic rim lesions” predicts greater multiple sclerosis (MS) related disability progression and clinical relapse frequency over 10 years.

Listen as Dr. Dejan Jakimovski joins the ReachMD radio program discussing his latest study and findings regarding severely affected people with multiple sclerosis.

At the Buffalo Neuroimaging Analysis Center (BNAC), we take the security and privacy of data very seriously. We are proud to hold the ISO 27001 certification, a testament to our unwavering commitment to the highest standards of information security and data protection. This prestigious certification is complemented by our ISO 9001:2015 certification, which covers our overall quality system, showcasing our comprehensive approach to excellence in all operational facets.

The Buffalo Neuroimaging Analysis Center (BNAC) enjoyed the spotlight at the recent European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) 2023 where its researchers were recognized for an unprecedented array of publications that are shaping the field of neuroimaging in multiple sclerosis (pwMS) and related disorders.

Recent advancements in multiple sclerosis (MS) research, including improved diagnostic criteria and novel MRI techniques, have been highlighted in a new Lancet paper by researchers from the Buffalo Neuroimaging Analysis Center (BNAC) and the Jacobs MS Center for Treatment and Research.

On October 5th Buffalo Neuroimaging Analysis Center celebrated the opening of its new headquarters located at the University at Buffalo's Downtown Gateway Building.

Buffalo Neuroimaging Analysis Center presents the Grand Opening of our New Offices on October 5th, 2023.

The massive 5.5-ton Philips MR 7700 that was installed in June in the Center for Biomedical Imaging (CBI) in UB’s Clinical and Translational Research Center (CTRC) is now operational.

Retinal nerve fiber thickness may serve as a potential biomarker for cognitive impairment in people with MS, possibly predicting future cognitive decline.

Robert Zivadinov, MD, Ph.D., has been named a SUNY Distinguished Professor – the highest faculty honor in the State University of New York (SUNY) system.

BNAC researchers develop a novel MRI technique that predicts staging of Paramagnetic Rim Lesions, a biomarker of chronic brain inflammation believed to be associated with progressive MS. They presented their work at ACTRIMS Forum 2023.

Each year, we share highlights of our patient-centered research, news about our scientists, core laboratory services, and our many collaborations at the Buffalo Neuroimaging Analysis Center. Thank you for taking an interest in our work. As always, we welcome your inquiries, comments, and suggestions and invite you to stay in touch with our progress on the developments that matter most to you.